Correction: MYC amplifications in myeloma cell lines: correlation with MYC-inhibitor efficacy

Oncotarget. 2018 Nov 13;9(89):36048. doi: 10.18632/oncotarget.26373.

Toril Holien¹, Kristine Misund¹, Oddrun Elise Olsen¹, Katarzyna Anna Baranowska¹, Glenn Buene¹, Magne Børset^{1

2}, Anders Waage^{1

3}, Anders Sundan^{1

4}

¹ K.G. Jebsen Center for Myeloma Research, Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway.
² Department of Immunology and Transfusion Medicine, St. Olav's University Hospital, Trondheim, Norway.
³ Department of Hematology, St. Olav's University Hospital, Trondheim, Norway.
⁴ CEMIR (Centre of Molecular Inflammation Research), Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway.

Abstract

[This corrects the article DOI: 10.18632/oncotarget.4245.].